Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing HPV Vaccine Introduction in Shanghai, China

NCT03972813 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT03972813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03972813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing HPV Vaccine Introduction in Shanghai, China
Lead sponsor
University of Michigan
Phase
Not applicable
Overall status
Terminated
Start date
May 28, 2019
Completion date
August 31, 2019
Enrollment
1,021 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vaccine refusal